Literature DB >> 7521102

Langerhans' cells and lymphocytic infiltrate in AIDS-associated Kaposi's sarcoma. An immunohistochemical study.

F Valcuende-Cavero1, M I Febrer-Bosch, A Castells-Rodellas.   

Abstract

The epidermal Langerhans' cells are dendritic cells of the skin capable of triggering cutaneous immune responses. They possess the membrane antigens required to this effect: class II histocompatibility antigen, CD1a and CD4; the latter acts as receptor for the human immunodeficiency virus. The skin is the organ primarily affected by Kaposi's sarcoma (KS). In epidemic KS, the local immunologic conditions of the skin are little known. We therefore studied 12 patients with AIDS-associated KS, evaluating the density and phenotypic expression in KS-affected and unaffected skin of the following antigens: CD1a, HLA-DR, CD4 in dendritic epidermal cells and dermis, and CD3, CD4 and CD8 in cells of the inflammatory infiltrate, using monoclonal antibodies applied to frozen sections with the avidin-biotin-peroxidase technique. Langerhans' cells in the AIDS-KS skin lesions were found to be decreased in number. This decrease was even more pronounced in the case of cells expressing HLA-DR antigen. A number of them were also revealed with CD4. The tumour lymphocytic infiltrate was almost exclusively composed of CD3+ CD8+ phenotype lymphocytes. The dermis also revealed CD4+ dendritic cells. The basal keratinocytes focally expressed HLA-DR. These phenotypical alterations of the Langerhans' cells and the local immunological imbalance observed may contribute to the growth and continuity of the KS lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521102     DOI: 10.2340/0001555574183187

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion.

Authors:  L M Butler; H C Jeffery; R L Wheat; P C Rae; K Townsend; K R Alkharsah; T F Schulz; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

3.  Pathology of rituximab-induced Kaposi sarcoma flare.

Authors:  Liron Pantanowitz; Klaus Früh; Sharon Marconi; Ashlee V Moses; Bruce J Dezube
Journal:  BMC Clin Pathol       Date:  2008-07-23

4.  Langerhans cells in cutaneous tumours: immunohistochemistry study using a computer image analysis system.

Authors:  Mario Ribeiro De Melo; Jorge Luiz Araújo Filho; Vasco José Ramos Patu; Marcos Cezar Feitosa Machado; Luciano Albuquerque Mello; Luiz B Carvalho
Journal:  J Mol Histol       Date:  2006-11-02       Impact factor: 3.156

Review 5.  Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses.

Authors:  Roberta Santarelli; Marisa Granato; Alberto Faggioni; Mara Cirone
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

Review 6.  Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma.

Authors:  Owen Ngalamika; Sody Munsaka
Journal:  J Immunol Res       Date:  2020-11-21       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.